Pharmaceuticals & Medicals
EPO applications defy economic slump with record-breaking 2011
Strong figures on European patent filing defy global economic conditions, as EPO creates team to fine tune its policies for working with emerging markets...  »
IP commercialisation highlights the value of patent analysis
As the economic significance of patents continues to grow, it’s more important than ever for IP managers to have a clear understanding of the value of the assets they and their competitors hold.&nbs....  »
UK-EU alignment an ‘immediate concrete benefit’ of bio-patent ruling
Last year, a biotech case over a protein patent caused a split between UK and European IP courts. Matt Packer finds out how a recent judgment has reconciled them...  »
Major WIPO report details surge in innovation industry
Organisation’s first World IP Report takes 40-year, panoramic view of an IP economy that is outpacing global GDP and driving change in poorer countries...  »
IP enforcement data hub called in for baggage search
A proposed database for boosting IP enforcement in Europe has been scrutinised for its potential impacts on privacy. Matt Packer listens in on the questioning...  »
Stem of innovation snipped in European biotech ruling?
Court of Justice judgment on German stem cell case could mar IP prospects for an entire division of scientific research...  »
New UK-IPO probe to cut through patent thickets
Economic effects of rights clusters to be the focus of special investigation with a report scheduled for the autumn...  »
Be sure to hit the IP Rights target in mergers and acquisitions
McDermot Will & Emery’s Carey C Jordan picks out the top five IP traps in M&A transactions...  »
Fears grow over high price of domain name fame
Experts at key US internet conference challenge brand confusion and financial risks posed by impending new domains...  »
Peering over examiner’s shoulder encouraged in patent project
A new online scheme allowing members of the public to comment on patent applications aims to raise IP quality in the UK and yield economic benefits, writes Matt Packer...  »